SUNSHINE BIOPHARMA INC (SBFM) Stock News
NASDAQ:SBFM - Nasdaq - US8677817004 - Common Stock - Currency: USD
SBFM Latest News, Press Relases and Analysis
All
Press Releases
13 days ago - ACCESS Newswire
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
2 months ago - ACCESS Newswire
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
3 months ago - ACCESS Newswire
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
3 months ago - ACCESS Newswire
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
3 months ago - ACCESS Newswire
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
3 months ago - ACCESS Newswire
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
3 months ago - ACCESS Newswire
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
4 months ago - ACCESS Newswire
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
6 months ago - ACCESS Newswire
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
10 months ago - FN Media Group LLC
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
10 months ago - FN Media Group LLC